Assessment of second-line antiretroviral regimens for HIV therapy in Africa
BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...
Glavni autori: | Paton, N, Kityo, C, Walker, A, al., E |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Massachusetts Medical Society
2014
|
Slični predmeti
-
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
od: Paton, N, i dr.
Izdano: (2014) -
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
od: Gomo, Z, i dr.
Izdano: (2014) -
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
od: Boender, T, i dr.
Izdano: (2016) -
Pediatric response to second-line antiretroviral therapy in South Africa.
od: Brian C Zanoni, i dr.
Izdano: (2012-01-01) -
Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
od: Hakim, J, i dr.
Izdano: (2017)